My Account
My Account
Mar 25, 2021 02:33 PM ISTMotilal Oswal is bullish on Divi’s Lab recommended buy rating on the stock with a target price of Rs 4530 in its research report dated March 24, 2021.
Mar 24, 2021 03:40 PM IST Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 4500 in its research report dated March 23, 2021.
Mar 22, 2021 03:05 PM IST According to ICICI Direct, Buy Divis Laboratories in the range of Rs 3280.00–3325.00 for target price of Rs 3740.00 with a stop loss of Rs 3110.00. Time Frame: Six months.
Feb 10, 2021 03:30 PM IST ICICI Direct is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 4440 in its research report dated February 06, 2021.
Feb 08, 2021 09:54 AM IST Since the macro context is fragile, eventually liquidity will continue to chase cash rich and cash flow positive businesses such as Divi’s Labs
Feb 05, 2021 12:25 PM IST We like the PI Industries' focus on custom synthesis and manufacturing which has helped it become a “partner of choice” for global agrochemical majors
Jan 25, 2021 09:35 AM IST We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers
Dec 30, 2020 12:42 PM IST ICICI Securities is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4425 in its research report dated December 30, 2020.
Dec 07, 2020 02:02 PM IST Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04, 2020.
Nov 11, 2020 11:30 AM IST Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06, 2020.
Nov 10, 2020 12:12 PM IST Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3900 in its research report dated November 08, 2020.
Nov 10, 2020 09:42 AM IST Divi's Labs result re-emphasise the fact that the global trend of de-risking supply chains away from China is adding to order enquires and product dispatches
Nov 09, 2020 01:38 PM IST Dolat Capital Market recommended accumulate rating on Divi's Laboratories with a target price of Rs 3515 in its research report dated November 08, 2020.
Nov 09, 2020 11:52 AM IST ICICI Direct is bullish on Divi's Laboratories recommended buy rating on the stock with a target price of Rs 4205 in its research report dated November 08, 2020.
Aug 11, 2020 06:59 PM IST Motilal Oswal is bullish on Divi’s Laboratories recommended buy rating on the stock with a target price of Rs 3350 in its research report dated August 09, 2020.
Aug 11, 2020 06:58 PM IST Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated August 07, 2020.
Aug 10, 2020 01:01 PM IST ICICI Direct is bullish on Divi's Laboratories has recommended buy rating on the stock with a target price of Rs 3260 in its research report dated August 09, 2020.
Aug 10, 2020 08:09 AM IST Divi’s ongoing capex plan should be helpful in capitalising on the opportunity stemmiing from drug shortages, the pandemic and the shift away from China
Jun 10, 2020 06:20 PM IST Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2700 in its research report dated June 08, 2020.
Jun 10, 2020 08:23 AM IST ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 2355 in its research report dated June 09, 2020.
Feb 24, 2020 10:40 AM IST Sharekhan is bullish on Divis Laboratories has recommended buy rating on the stock with a target price of Rs 2430 in its research report dated February 20, 2020.
Feb 10, 2020 03:48 PM IST Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 2200 in its research report dated February 06, 2020.
Nov 07, 2019 03:03 PM IST ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1850 in its research report dated November 06, 2019.
Aug 19, 2019 03:50 PM IST Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated August 14, 2019.
Aug 13, 2019 01:07 PM IST ICICI Direct recommended hold rating on Divi's Laboratories with a target price of Rs 1640 in its research report dated August 12, 2019.
